ITMI910253A0 - Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale - Google Patents

Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale

Info

Publication number
ITMI910253A0
ITMI910253A0 IT91MI253A ITMI910253A ITMI910253A0 IT MI910253 A0 ITMI910253 A0 IT MI910253A0 IT 91MI253 A IT91MI253 A IT 91MI253A IT MI910253 A ITMI910253 A IT MI910253A IT MI910253 A0 ITMI910253 A0 IT MI910253A0
Authority
IT
Italy
Prior art keywords
prevention
post
treatment
pharmaceutical association
menopausal osteoporosis
Prior art date
Application number
IT91MI253A
Other languages
English (en)
Inventor
Paolo Chiesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ITMI910253A0 publication Critical patent/ITMI910253A0/it
Priority to ITMI910253A priority Critical patent/IT1244697B/it
Priority to IE021992A priority patent/IE920219A1/en
Priority to NZ241418A priority patent/NZ241418A/xx
Priority to PCT/EP1992/000174 priority patent/WO1992013538A1/en
Priority to HU9302183A priority patent/HUT64848A/hu
Priority to AU11884/92A priority patent/AU1188492A/en
Priority to EP92903484A priority patent/EP0569415A1/en
Priority to CA002101547A priority patent/CA2101547A1/en
Priority to ZA92661A priority patent/ZA92661B/xx
Publication of ITMI910253A1 publication Critical patent/ITMI910253A1/it
Application granted granted Critical
Publication of IT1244697B publication Critical patent/IT1244697B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI910253A 1991-02-01 1991-02-01 Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale IT1244697B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI910253A IT1244697B (it) 1991-02-01 1991-02-01 Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale
IE021992A IE920219A1 (en) 1991-02-01 1992-01-24 Pharmaceutical combination for the prevention and treatment¹of postmenopausal osteoporosis
NZ241418A NZ241418A (en) 1991-02-01 1992-01-27 Synergistic compositions comprising ipriflavone and at least one oestrogen
HU9302183A HUT64848A (en) 1991-02-01 1992-01-28 Medical preparatives for preventing and treating osteoporises after menopausa
PCT/EP1992/000174 WO1992013538A1 (en) 1991-02-01 1992-01-28 Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis
AU11884/92A AU1188492A (en) 1991-02-01 1992-01-28 Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis
EP92903484A EP0569415A1 (en) 1991-02-01 1992-01-28 Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis
CA002101547A CA2101547A1 (en) 1991-02-01 1992-01-28 Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis
ZA92661A ZA92661B (en) 1991-02-01 1992-01-30 Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910253A IT1244697B (it) 1991-02-01 1991-02-01 Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale

Publications (3)

Publication Number Publication Date
ITMI910253A0 true ITMI910253A0 (it) 1991-02-01
ITMI910253A1 ITMI910253A1 (it) 1992-08-01
IT1244697B IT1244697B (it) 1994-08-08

Family

ID=11358374

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910253A IT1244697B (it) 1991-02-01 1991-02-01 Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale

Country Status (9)

Country Link
EP (1) EP0569415A1 (it)
AU (1) AU1188492A (it)
CA (1) CA2101547A1 (it)
HU (1) HUT64848A (it)
IE (1) IE920219A1 (it)
IT (1) IT1244697B (it)
NZ (1) NZ241418A (it)
WO (1) WO1992013538A1 (it)
ZA (1) ZA92661B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6635994A (en) * 1993-04-16 1994-11-08 Tufts University School Of Medicine Method for treatment of menopausal and premenstrual symptoms
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition
US6319914B1 (en) 1993-11-05 2001-11-20 Apollo Biopharmaceuticals, Inc. Cytoprotective effect of polycyclic phenolic compounds
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US6339078B1 (en) 1999-07-20 2002-01-15 University Of Florida Research Foundation, Inc. Methods of prevention and treatment of ischemic damage
US6326365B1 (en) 1999-07-20 2001-12-04 Apollo Biopharmaceutics, Inc. Methods of prevention and treatment of ischemic damage
MXPA03008366A (es) * 2001-03-16 2004-11-12 Wyeth Corp Terapia de reemplazamiento de estrogenos.
US20080199546A1 (en) * 2006-10-24 2008-08-21 Krempin David W Anti-resorptive and bone building dietary supplements and methods of use

Also Published As

Publication number Publication date
WO1992013538A1 (en) 1992-08-20
HU9302183D0 (en) 1993-10-28
HUT64848A (en) 1994-03-28
NZ241418A (en) 1993-03-26
ITMI910253A1 (it) 1992-08-01
ZA92661B (en) 1992-10-28
CA2101547A1 (en) 1992-08-02
IT1244697B (it) 1994-08-08
EP0569415A1 (en) 1993-11-18
AU1188492A (en) 1992-09-07
IE920219A1 (en) 1992-08-12

Similar Documents

Publication Publication Date Title
ITMI921325A1 (it) Procedimento e dispositivo per il trattamento dell'obesita' di un paziente
IT8909525A0 (it) Apparecchio per il trattamento dell'intestino
ITFI910071V0 (it) Piastra per osso per la porzione distale dell'omero
ITMI910253A1 (it) Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale
FI962685A (fi) 2,3-diaryyli-1-bentsopyraanijohdannaisten käyttö lääkkeen valmistamiseksi luukadon ja osteoporoosin hoitamiseksi ja estämiseksi
ITMI913465A0 (it) Procedimento per la depurazione dell'1.1.1-trifluoro-2-fuoroetano
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
ITRM940806A0 (it) Preparato per il trattamento dell'obesita'
IT1252659B (it) Procedimento per la depurazione dell'1,1,1-trifluoro-2-fluoroetano e dell'1,1,1-trifluoro-2,2-dicloroetano
ITMI931371A1 (it) Procedimento per la preparazione dell'erdosteina
RU1833735C (ru) Cпocoб лeчehия ctepoидopeзиctehthыx фopm пузыpчatkи
ITMI912019A1 (it) Analoghi dell'irudina e procedimento per la loro preparazione
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
IT8719390A0 (it) Composizione farmaceutica per la prevenzione e il trattamento dell'aterosclerosi.
IT9003672A0 (it) Apparecchiatura per il controllo e la prevenzione dell'effetto nebbioso.
ITMI921785A1 (it) Procedimento per la sintesi dell'1-4-butandiolo
HUP0000476A3 (en) Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
IT225039Z2 (it) Manipolo per sollecitazioni elettrostatiche dell'epidermide
ITMI940205A0 (it) Composti lattonici utili per il trattamento dell'osteoporosi
ITMI940201A0 (it) Composti lattonici utili per il trattamento dell'osteoporosi
ITGE910094A0 (it) Prodotto per la cura e la prevenzione del cancro e dell'aids
ITMI911450A0 (it) Endoapparecchio per il ripristino dell'articolazione coxofemorale
IT1192034B (it) Calzatura anatomica per la prevenzione e la correzione dell'alluce valgo
IT8604886V0 (it) Calzatura anatomica per la prevenzione e la correzione dell'alluce valgo
ITMI910558A0 (it) Apparecchiatura per l'idropressozonoterapia drenante

Legal Events

Date Code Title Description
0001 Granted